Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$7.46 - $19.28 $877,430 - $2.27 Million
-117,618 Reduced 24.19%
368,542 $4.06 Million
Q2 2022

Aug 11, 2022

BUY
$15.06 - $30.65 $22,213 - $45,208
1,475 Added 0.3%
486,160 $7.87 Million
Q1 2022

May 13, 2022

BUY
$23.26 - $42.41 $79,595 - $145,127
3,422 Added 0.71%
484,685 $14.1 Million
Q4 2021

Feb 11, 2022

SELL
$37.54 - $57.51 $50,115 - $76,775
-1,335 Reduced 0.28%
481,263 $20.4 Million
Q3 2021

Nov 12, 2021

SELL
$45.91 - $59.67 $66,707 - $86,700
-1,453 Reduced 0.3%
482,598 $24 Million
Q2 2021

Aug 13, 2021

BUY
$43.3 - $67.17 $8.7 Million - $13.5 Million
200,839 Added 70.91%
484,051 $28.4 Million
Q1 2021

May 13, 2021

SELL
$44.11 - $90.64 $71,634 - $147,199
-1,624 Reduced 0.57%
283,212 $16.6 Million
Q4 2020

Feb 10, 2021

BUY
$33.89 - $49.88 $9.65 Million - $14.2 Million
284,836 New
284,836 $13.2 Million

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $436M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.